Core A continues to administer the overall Program Project, and to manage the Database. This involves interacting with three cores, 4 subprojects, and with NIA officials and an External Advisory Board (in the US) and a Guam Community Advisory Board.
The specific aims of core A are as follows: 1) Facilitate the overall goals of the program project, provide administrative support for all cores and projects, and maintain liaison with participating institutions on Guam, in San Diego, New York, Philadelphia, Seattle, Portland (OR) and Tampa (FLA), and with NIA program staff; 2) Monitor and maintain subject enrollment of subjects into the Clinical core and entry into research projects; 3) Maintain and manage a common database of all Clinical and Pathology core data and stored DNA and blood samples; ensure quality control and security; facilitate sharing of data between investigators; coordinate and provide support for data analyses; 4) Schedule communication and meetings between investigators, consultants, the executive committee, the External Advisory Committee and Guam Advisory Board; 5) Promote and facilitate sharing of resources and tissue with investigators outside the Program Project; 6) Review on an ongoing basis the scientific progress of the Program Project; 7) Review the utilization of funds; 8) Monitor and review all educational and training activities; 9) Monitor investigator and staff compliance with Human Subjects education and regulations.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Research Program Projects (P01)
Project #
2P01AG014382-06
Application #
6481377
Study Section
Special Emphasis Panel (ZAG1-FAS-7 (J4))
Project Start
1997-03-01
Project End
2007-03-31
Budget Start
Budget End
Support Year
6
Fiscal Year
2002
Total Cost
$177,940
Indirect Cost
Name
University of California San Diego
Department
Type
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Dombroski, Beth A; Galasko, Douglas R; Mata, Ignacio F et al. (2013) C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complex. JAMA Neurol 70:742-5
Brunden, Kurt R; Ballatore, Carlo; Lee, Virginia M-Y et al. (2012) Brain-penetrant microtubule-stabilizing compounds as potential therapeutic agents for tauopathies. Biochem Soc Trans 40:661-6
Lee, Virginia M-Y; Brunden, Kurt R; Hutton, Michael et al. (2011) Developing therapeutic approaches to tau, selected kinases, and related neuronal protein targets. Cold Spring Harb Perspect Med 1:a006437
Yu, Chang-En; Bird, Thomas D; Bekris, Lynn M et al. (2010) The spectrum of mutations in progranulin: a collaborative study screening 545 cases of neurodegeneration. Arch Neurol 67:161-70
Brunden, Kurt R; Ballatore, Carlo; Crowe, Alex et al. (2010) Tau-directed drug discovery for Alzheimer's disease and related tauopathies: a focus on tau assembly inhibitors. Exp Neurol 223:304-10
Crowe, Alex; Huang, Wenwei; Ballatore, Carlo et al. (2009) Identification of aminothienopyridazine inhibitors of tau assembly by quantitative high-throughput screening. Biochemistry 48:7732-45
Brunden, Kurt R; Trojanowski, John Q; Lee, Virginia M-Y (2009) Advances in tau-focused drug discovery for Alzheimer's disease and related tauopathies. Nat Rev Drug Discov 8:783-93
Snyder, L R; Cruz-Aguado, R; Sadilek, M et al. (2009) Lack of cerebral bmaa in human cerebral cortex. Neurology 72:1360-1
Choi, Yoonha; Wijsman, Ellen M; Weir, Bruce S (2009) Case-control association testing in the presence of unknown relationships. Genet Epidemiol 33:668-78
Sieh, Weiva; Choi, Yoonha; Chapman, Nicola H et al. (2009) Identification of novel susceptibility loci for Guam neurodegenerative disease: challenges of genome scans in genetic isolates. Hum Mol Genet 18:3725-38

Showing the most recent 10 out of 53 publications